ATARA Biotherapeutics (ATRA) Tops Q1 EPS by 350c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of $3.50. Revenue for the quarter came in at $98.15 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Tilray Brands acquires HelloMD to expand Canadian cannabis platform
• After-Hours Stock Movers: AVAV, PRAX, VSH, CNXC, SHAZ